文献速递认知障碍与谵妄老年综合评估老年慢病共病管理

两年多领域生活方式干预中CAIDE痴呆风险评分变化与神经影像生物标志物的关联

Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2021-01-01

该研究为FINGER试验的事后亚组分析,纳入60-77岁有痴呆风险的老年人,随机接受多领域干预或对照。结果显示干预组中CAIDE评分降低(痴呆风险下降)与海马体积下降更少相关(交互项β=-0.40,p=.02),其他影像指标无显著关联。

要点

  • 干预组中CAIDE评分降低与海马体积下降更少相关,对照组无此关联。
  • 其他MRI指标及PiB-PET measures与CAIDE评分变化无显著关联。
  • 该探索性发现需更大规模研究验证。

核心结论

  • 在多领域生活方式干预中,CAIDE评分降低(痴呆风险下降)可能与海马体积下降更少相关,但仅见于干预组。

研究设计与样本

  • FINGER随机对照试验的事后亚组分析,纳入60-77岁有痴呆风险的普通人群老年人,随机分为多领域干预组(饮食、运动、认知训练、血管风险管理)或对照组(一般健康建议)。
  • 112名参与者有重复脑MRI数据,39名有重复PiB-PET数据。

主要发现

  • 干预期间CAIDE评分降低与干预组海马体积下降更少相关,对照组无此关联(随机化分组×CAIDE变化交互项β=-0.40,p=.02)。
  • 其他神经影像指标(总灰质体积、白质病变体积、阿尔茨海默病特征性皮层厚度及PiB-PET measures)的关联均不显著。

关键数值与推荐

  • CAIDE评分降低与海马体积下降更少的交互项β=-0.40,p=.02(干预组 vs 对照组)。

临床怎么用

  • 对于有痴呆风险的老年人,通过多领域生活方式干预降低CAIDE评分可能有助于减缓海马体积萎缩,但需个体化评估。

局限性

  • 本研究为探索性事后分析,样本量有限(MRI n=112,PiB-PET n=39),结果需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The CAIDE (Cardiovascular Risk Factors, Aging and Dementia) Risk Score is a validated tool estimating dementia risk. It was previously associated with imaging biomarkers. However, associations between dementia risk scores (including CAIDE) and dementia-related biomarkers have not been studied in the context of an intervention. This study investigated associations between change in CAIDE score and change in neuroimaging biomarkers (brain magnetic resonance imaging [MRI] and Pittsburgh Compound B-positron emission tomography [PiB-PET] measures) during the 2-year Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (post-hoc analyses). FINGER targeted at-risk older adults, aged 60-77 years, from the general population. Participants were randomized to either multidomain intervention (diet, exercise, cognitive training, and vascular risk management) or control group (general health advice). Neuroimaging (MRI and PiB-PET) data from baseline and 2-year visits were used. A toal of 112 participants had repeated brain MRI measures (hippocampal, total gray matter, and white matter lesion volumes, and Alzheimer's disease signature cortical thickness). Repeated PiB-PET scans were available for 39 participants. Reduction in CAIDE score (indicating lower dementia risk) during the intervention was associated with less decline in hippocampus volume in the intervention group, but not the control group (Randomization group × CAIDE change interaction β coefficient = -0.40, p = .02). Associations for other neuroimaging measures were not significant. The intervention may have benefits on hippocampal volume in individuals who succeed in improving their overall risk level as indicated by a reduction in CAIDE score. This exploratory finding requires further testing and validation in larger studies.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Stephen R, Ngandu T, Liu Y, et al. Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis. J Gerontol A Biol Sci Med Sci. 2021. PMID: 33970268. doi:10.1093/gerona/glab130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。